Nuclear medicine is significantly improving the survival rates and quality of life for men with advanced prostate cancer in Malaysia, according to Dr. Andik Fadilah Abdul Aziz from Thomson Hospital Kota Damansara. Patients who previously experienced severe symptoms and limited mobility have seen remarkable recoveries after receiving targeted nuclear medicine therapy, particularly through PSMA PET/CT scans and radioligand therapy (RLT). These advancements allow for more precise detection and treatment of prostate cancer, often when it has progressed beyond early stages. However, many patients in Malaysia are diagnosed late, partly due to the misconception that urinary symptoms are a natural part of aging. Dr. Fadilah emphasizes the importance of early detection and awareness to improve outcomes. Although access to nuclear medicine is currently limited, efforts are underway to expand services and educate both physicians and the public about these advanced treatment options. As awareness grows, there is optimism that nuclear medicine will become a standard part of prostate cancer care in the coming years.
Thu, 25 Sep 2025 06:18:32 GMT | CodeBlue